Position in AZN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$717,508,237
-$28,757,845 QoQ
Shares Held
3,783,927
0.0% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
3.17%
of 13F equity value
Holder Rank
#47
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DekaBank Deutsche Girozentrale holds $3,270,490,110 across 11 Drug Manufacturers - General names. AZN ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,411,321 | $1,120,343,194 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
3,783,927 | $717,508,237 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,427,912 | $697,486,691 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,040,494 | $257,796,011 | |
| 5 | AMGN |
Amgen Inc
|
711,647 | $257,701,611 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,782,490 | $217,947,072 | |
| 7 | LLY |
ELI LILLY & Co
|
915,360 | $831,293 | |
| 8 | ABBV |
AbbVie Inc.
|
3,054,882 | $648,674 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $717,508,237 | 3,783,927 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $746,266,082 | 3,783,927 | Shares | Defined | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||